Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-16

FDA Approved: DESVENLAFAXINE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved the original ANDA for desvenlafaxine submitted by Hikma Pharmaceuticals USA Inc., providing a generic option for this antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)

Snippet

ORIG AP for DESVENLAFAXINE (DESVENLAFAXINE)